Vascular tumors of intermediate malignancy: An update.

Hum Pathol

Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, 55902, United States. Electronic address:

Published: May 2024

The term "hemangioendothelioma" is used for endothelial neoplasms of intermediate malignancy and describes a group of rare neoplasms having biologic behavior falling in between that of the benign hemangiomas and fully malignant angiosarcomas. The hemangioendotheliomas fall into several specific, clinicopathologically and genetically distinct entities, specifically epithelioid hemangioendothelioma, kaposiform hemangioendothelioma, papillary intralymphatic angioendothelioma and retiform hemangioendothelioma (hobnailed hemangioendothelioma), pseudomyogenic hemangioendothelioma, composite hemangioendothelioma, and YAP1::TFE3-fused hemangioendothelioma. The clinical, morphologic, immunohistochemical, and genetic features, and the differential diagnosis of each of these rare entities are discussed in this review.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.humpath.2024.01.014DOI Listing

Publication Analysis

Top Keywords

intermediate malignancy
8
hemangioendothelioma
7
vascular tumors
4
tumors intermediate
4
malignancy update
4
update term
4
term "hemangioendothelioma"
4
"hemangioendothelioma" endothelial
4
endothelial neoplasms
4
neoplasms intermediate
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!